CoVimmune COVID-19免疫计算器:网络应用程序开发和验证研究
Rebecca Slotkin1, Tassos C Kyriakides2,3, Vinni Yu4
1Department of Medicine, Yale School of Medicine, 950 Campbell Ave, Bldg 1, Floor 5, West Haven, CT, 06516, United States, 1 2038005320.
JMIR formative research
|April 22, 2025
概括
一个新的网络工具从疫苗接种成人的血清免疫球蛋白G (IgG) 水平估计了SARS-CoV-2中和抗体 (nAb) 标位. 这个计算器有助于评估疫苗诱导的对COVID-19的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 研究血清抗SARS-CoV-2S1/受体结合域免疫球蛋白G (IgG) 和中和抗体 (nAb) 标位之间的相关性.
- 在美国成年人群中,在接种疫苗后的不同时间点分析nAb标位.
研究的目的:
- 开发一种可访问的基于网络的计算器,以使用商业抗SARS-CoV-2血清IgG结果近似估计SARS-CoV-2中和能力.
- 为预测nAb标位提供以患者为中心的工具.
主要方法:
- 利用两个已发表的数据集:一个显示IgG-nAb相关性,另一个跟踪疫苗接种后的nAb标位.
- 从线性回归模型中纳入了统计学上显著的临床因素,预测了从IgG.到nAb的IgG.
- 开发了一个公开可用的网络应用程序,用于用户输入血清IgG值.
主要成果:
- 该应用程序根据用户提供的血清IgG值提供了估计的nAb标位.
- 估计的nAb标位与理论的疫苗介导抗体保护水平相联系.
- 显著影响IgG对nAb的预测的临床变量被用于以患者为中心的预测.
结论:
- 开发的应用程序将保护性抗体的科学研究与临床实践联系起来.
- 为评估疫苗诱导的针对SARS-CoV-2的免疫力提供了一个实用的工具.
- 展示了基于Web的应用程序在将免疫学研究成果转化为临床用途方面的潜力.
相关概念视频
01:40Cell-mediated Immune Responses
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...